EGM
HZNP

Engineers Gate Manager’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Engineers Gate Manager’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,818
Closed -$1.02M – 2355
2023
Q3 		$1.02M Buy
8,818
+618
+8% +$66.4K 0.04% 697
2023
Q2 		$843K Sell
8,200
-2,916
-26% -$308K 0.03% 779
2023
Q1 		$1.21M Buy
11,116
+4,228
+61% +$467K 0.05% 521
2022
Q4 		$784K Sell
6,888
-5,396
-44% -$448K 0.05% 624
2022
Q3 		$760K Sell
12,284
-39,816
-76% -$2.78M 0.05% 566
2022
Q2 		$4.16M Buy
52,100
+21,453
+70% +$2.03M 0.15% 150
2022
Q1 		$3.22M Buy
30,647
+19,602
+177% +$1.91M 0.13% 183
2021
Q4 		$1.19M Buy
11,045
+8,385
+315% +$915K 0.05% 524
2021
Q3 		$291K Buy
+2,660
New +$276K 0.02% 1209
2021
Q1 		– Sell
-62,907
Closed -$4.6M – 2249
2020
Q4 		$4.6M Buy
62,907
+52,965
+533% +$3.94M 0.2% 102
2020
Q3 		$772K Buy
+9,942
New +$684K 0.04% 761
2020
Q2 		– Sell
-41,844
Closed -$1.24M – 2105
2020
Q1 		$1.24M Buy
+41,844
New +$1.42M 0.09% 340
2019
Q2 		– Sell
-12,800
Closed -$338K – 1498
2019
Q1 		$338K Buy
+12,800
New +$303K 0.02% 715

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Engineers Gate Manager's HZNP Position: Q4 2023 in Review

Engineers Gate Manager sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 8,818 shares — an estimated $1.02M sold.

Engineers Gate Manager first reported a position in HZNP in Q1 2019 and held it in 13 quarters. The position peaked at $4.6M in Q4 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Engineers Gate Manager reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Engineers Gate Manager sold 8,818 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.02M.
  • Engineers Gate Manager first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 13 quarters.
  • Engineers Gate Manager's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.6M in Q4 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Engineers Gate Manager's 13F filing for Q4 2023, filed 14 Feb 2024.